TOLERA THERAPEUTICS INC

Profile

Company Names

TOLERA THERAPEUTICS INC

Addresses

350 EAST MICHIGAN AVENUE, SUITE 205, KALAMAZOO, MI 49007

Phone Numbers

(269) 585-2100

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$13,863,391.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2014-09-11 
$250,000.00 
INDEFINITE 
INDEFINITE 
Debt 
6
2013-09-27 
$1,052,710.00 
INDEFINITE 
INDEFINITE 
Debt 
5
2012-10-03 
$5,406,298.00 
$5,406,298.00 
$0.00 
Equity 
4
2012-08-10 
$750,050.00 
$750,050.00 
$0.00 
Debt 
3
2012-05-02 
$1,465,000.00 
$2,000,000.00 
$535,000.00 
Debt 
2
2011-12-12 
$883,333.00 
$1,650,000.00 
$766,667.00 
Debt 
1
2010-05-21 
$4,056,000.00 
$6,140,000.00 
$2,084,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SUZETTE 
 
DUTCH 
DIRECTOR
BIOVEX GROUP, INC.   |  TOLERA THERAPEUTICS INC   |  JUVENTAS THERAPEUTICS INC
JAMES 
 
HERRMANN 
EXECUTIVE OFFICER
TOLERA THERAPEUTICS INC   |  COUR PHARMACEUTICALS DEVELOPMENT CO INC
DOUGLAS 
 
MORTON 
DIRECTOR
NEPHRX CORP   |  TOLERA THERAPEUTICS INC   |  TETRA DISCOVERY PARTNERS, INC.
MARK 
 
OLESNAVAGE 
DIRECTOR
TOLERA THERAPEUTICS INC   |  METABOLIC SOLUTIONS DEVELOPMENT CO   |  METABOLIC SOLUTIONS DEVELOPMENT CO LLC   |  INTERVENTION INSIGHTS, INC.   |  HOPEN LIFE SCIENCE FUND II LP   |  CIRIUS THERAPEUTICS, INC.
ASHLEIGH 
 
PALMER 
EXECUTIVE OFFICER
TARSA THERAPEUTICS, INC.   |  UNIGENE LABORATORIES INC   |  TOLERA THERAPEUTICS INC   |  THIRD POLE, INC.   |  PROVENTION BIO, INC.
DONALD 
 
PARFET 
DIRECTOR
NEPHRX CORP   |  TOLERA THERAPEUTICS INC   |  APJOHN VENTURES ANNEX FUND, LIMITED PARTNERSHIP   |  PRONAI THERAPEUTICS INC   |  TETRA DISCOVERY PARTNERS, INC.   |  IASO THERAPEUTICS, INC.
JOHN 
 
PUISIS 
EXECUTIVE OFFICER, DIRECTOR
TOLERA THERAPEUTICS INC   |  PRONAI THERAPEUTICS INC   |  COUR PHARMACEUTICALS DEVELOPMENT CO INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-09-17
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-09-11 
2013-10-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2013-09-27 
2012-10-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-03 
2012-08-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-10 
2012-05-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-05-02 
2011-12-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2011-12-12 
2010-06-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-05-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#